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Of the countless lifestyle adaptations required by hemodialysis patients, behavioral changes associated with
the management of hyperphosphatemia, such as the
adoption of a low phosphate diet and judicious intake of
phosphate binders, are probably the most complicated
and challenging [1,2]. Non-adherence to low phosphate
diets, which are likely the most common dietary restrictions required from this patient population, ranges
between 19 and 57% [3,4]. Likewise, non-adherence to
phosphate binders is common, ranging between 22 and
74%, with more than half of hemodialysis patients not
following their prescribed regimens [5]. In line with this
background, it is unsurprising that more than a decade
after the first international clinical practice guidelines for
chronic kidney disease-mineral bone disorder were issued [6], a wide gap persists between recommended and
measured serum phosphorus levels among hemodialysis
patients in clinical practice. Hyperphosphatemia is the
most common mineral abnormality among this patient
population, with nearly one in two hemodialysis patients
being hyperphosphatemic [3]. While the pharmaceutical
industry has responded by developing new agents, little
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importance has been given to patient education programs, specifically counseling to foster behavioral changes, in clinical practice, despite mounting high-quality
evidence regarding the effectiveness of this intervention
[7].
In this issue of Kidney Research and Clinical Practice ,
Lim et al [8] assessed the impacts of nutrition and pharmacologic education on serum phosphate, calciumphosphate product, and adherence to a low phosphate
diet, i.e., dietary phosphate intake and phosphorus-toprotein ratio, self-reported compliance with phosphate
binder prescriptions, prescribed bioequivalent dose of
binders and knowledge regarding proper intake timing,
as well as nutritional status, among other parameters.
After random assignment to experimental groups, 48
patients received one 30-minute individualized educational session with a dietitian and another session with
a pharmacist, while the control group received conventional care without education sessions. The investigators
explored changes over the short (one-month post-education) and long-term (two or three months post-education). The authors reported no significant changes in any
of the study parameters between the intervention and
the control groups, either over the short- or long-term.
The absence of any effect associated with patient education intervention could be partly explained by the study
limitations acknowledged by the authors, specifically, the
baseline parameters of the sample. More than two-thirds
of the study sample had good phosphate control, and
mean baseline serum phosphate levels that were within
the recommended range according to international renal
guidelines [6]; moreover, the mean baseline compli-
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ance score was medium. These figures are suggestive of
good adherence to treatment among the patients in the
study sample, which is unlike the situation commonly
observed among hemodialysis patients described in the
international literature. The lack of elucidation regarding
essential features to design a successful patient education program for optimal hyperphosphatemia management may also explain the absence of any effect associated with the intervention. Specifically, the most valuable
features may include sustainability of at least monthly
education, for over 6 months, as well as a focus on counseling for behavioral change, rather than solely focusing
on the transfer of knowledge [9].
It is becoming incumbent upon the healthcare profes-

sional community to acknowledge that education programs are indispensable for the optimal management of
hemodialysis patients in routine care. It is also essential
to recognize that in conjunction with these programs,
refining patient knowledge alone does not lead to actual
behavioral changes and improvements in outcomes, specifically for hyperphosphatemia management. Indeed,
there is evidence that hemodialysis patients with better
knowledge actually have worse phosphate control [4],
because reasons for non-adherence to the treatment of
hyperphosphatemia in end-stage renal disease extend
beyond poor knowledge. Important factors include patient demographic, clinical, personality and psychosocial
characteristics. such as the beliefs about the necessity of

Table 1. Features of a comprehensive and effective patient education program to manage hyperphosphatemia in hemodialysis
patients (adapted from references [2] and [9])
Component
Human

Information

Counseling theory
and strategy
Format
Tools

Timing
Duration
Frequency
Binder properties

Features
Led by trained nurses, dietitians or other ancillary healthcare providers
Multidisciplinary team approach where depression is also treated
Patients involved in preparation of the intervention
Patients’ families and friends involved in education initiatives
Hyperphosphatemia, its complications, and means of control
Relevant blood tests, and review of blood tests’ results with the patient
Dietary:
• Appropriate food choices
• Phosphorus-to-protein ratio of foods
• Avoidance of phosphate additives
• Training to prepare suitable meals
Phosphate binder:
• Mode of action
• Role and benefit in lowering serum phosphate
Use of counseling theories, such as the trans theoretical model of behavioral change
Use of counseling strategies, such as motivational interviewing, self-monitoring, and self-regulation
Initiatives for patient empowerment, such as the Phosphate Education Program
Individualized (one-on-one) or group education
Tailored to the patient’s lifestyle, environment, career, ethnicity, cultural background, and socioeconomic status
Handouts and visual tools: colorful informational booklets; lists of common phosphate-rich and -poor foods;
food alternatives; posters
Games and puzzles
Recipes adapted to taste and culture
Before the hemodialysis session
At least 6 months
At least monthly
Reduce pill size and burden
Improve palatability
Reduce associated adverse effects
Introduce electronic monitoring devices (to help patients to remember to take their medication and support adherence)

www.krcp-ksn.org

5

Kidney Res Clin Pract Vol. 37, No. 1, March 2018

6

www.krcp-ksn.org

C, control; I, intervention.
*Values adjusted to baseline differences.

Randomized controlled trial:
I: 30 minutes of comprehensive,
culturally-validated,
individualized behavioral nutrition
education provided by trained dietitians,
using varied educational material,
for 6 months
C: standard education by hospital
dietitians
Rodriguez-Palomares n = 35 (18 on hemodialysis; Pre-post intervention:
et al (Spain) [12]
17 on peritoneal dialysis) Educational workshop on the consequences
of uncontrolled phosphate, identification
Age (yr): 59.37 (14.9)
and appropriate methods of administration
Gender (male): 57%
of binders, identification of high-phosphate
foods, reducing oral intake

Design & intervention
Participants

I (n = 116)
C (n = 130)
Age (yr):
I: 57.56 (15.18)
C: 59.96 (15.22)
Gender (male):
I: 56.9%
C: 55.4%
Rizk et al (Lebanon)
[11]

Given continually rising healthcare costs and limited
budgets, cost considerations are gaining more and more
attention in decisions about adoption of health technologies. There is little doubt that patient education is a
promising and economically attractive intervention in
hyperphosphatemia management. Emerging evidence

Study (country)

Patient education: an economically attractive
alternative?

Table 2. Cost savings of patient education programs for hyperphosphatemia management

“One of the greatest opportunities to improve patient
outcomes will probably come not from discovering new
treatments, but from more effective delivery of existing
therapies ” [10]. Patient education programs are uniquely
potent in this regard. Undeniably, whenever trialed or
meta-analyzed, patient education has proven to be an
effective adjunct to other means of hyperphosphatemia
management [7]. It is now well established that frequent,
long-term, individualized education, delivered by trained
healthcare professionals using cognitive and/or behavioral strategies and providing patients with problemsolving skills and ongoing reinforcement, is an effective
approach for managing hyperphosphatemia among
hemodialysis patients without compromising their nutritional status [2,9]. Table 1 delineates essential features of
an effective patient education program for controlling serum phosphate. Education for hyperphosphatemia management should be sustained in all patients, including
those who are compliant, in order to ensure they maintain healthy behaviors and subsequently normal serum
phosphate levels [1].

Costs included

Effective patient education for hyperphosphatemia
management: how can we achieve that?

Healthcare sector costs: dietetic
intervention, hemodialysis,
emergency hemodialysis,
healthcare professional
consultation, hospitalization,
medications, integrated home care
Costs to patient and family:
caregiver costs, productivity losses
Travel costs
-175.16€ per patient
Calcium-based and non-calcium-based Pre: 5.0 (1.5)
phosphate binders
Post: 4.4 (1.4)
per month
(P < 0.05)
% patients with controlled
phosphate:
Pre: 40%; Post: 71%

Impact on serum
Cost savings
phosphate (mg/dL)
-106.05$ per patient
Baseline:
I: 5.57 (1.52)
per month between
C: 5.39 (1.49)
the intervention and
6-month post-intervention: control groups
I: 5.25 (1.39)*
C: 5.55 (1.75)*
(P < 0.05)

and concerns about the potential adverse consequences
of phosphate binders, as well as food fatigue, or gradually
becoming disinterested and subsequently less adherent
to the low phosphate diet, in addition to perceived social
support from friends, family and renal staff [1,5].
When educating hemodialysis patients on serum phosphate control, educators should shift from traditional
knowledge-based, expert-centered guidance, to patientcentered counseling approaches that focus on empowerment and shared decision-making, with an ultimate goal
of fostering behavioral change and preventing relapse [9].
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clearly indicates that patient education has low direct
costs and is an inexpensive intervention within hemodialysis care [9]. The implementation of this intervention
could generate tremendous cost savings and significant
clinical improvement [11,12]. Rizk et al [11] found that
the cost savings generated by the implementation of an
intensive nutrition education for hyperphosphatemia
management in hemodialysis units offsets the cost of the
education program more than eight times. Table 2 provides examples of the monumental cost-saving impacts
of two patient education programs targeting low phosphate diet and phosphate binder intake, respectively.
Accordingly, it seems reasonable to plan a powered randomized controlled trial, extended with a model-based
analysis, that is specifically designed to investigate the
cost-effectiveness of patient education programs for hyperphosphatemia management in hemodialysis patients.
The provision of solid evidence about the economic efficiency of this intervention could encourage health policymakers to implement similar programs in routine clinical practice. This may in turn contribute to more efficient
allocation of public health budgets, while simultaneously
enhancing quality of care and patient outcomes.
In conclusion, patient-tailored counseling and sufficient
time spent with patients are associated with improvements in serum phosphate control, as long as constant
reinforcement measures are in place. Patient education
programs could also provide valuable opportunities for
containing costs, which are much-needed in modern nephrology care.
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